1947 — Meihao Medical Co Balance Sheet
0.000.00%
- HK$213.05m
- HK$168.23m
- CNY74.68m
- 56
- 19
- 35
- 26
Annual balance sheet for Meihao Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 51 | 41.3 | 89.5 | 142 | 78.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.995 | 4.44 | 82.5 | 5.02 | 12.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 63.4 | 55.4 | 177 | 152 | 98.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 31.2 | 71.3 | 64.4 | 61.7 | 58.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 98.4 | 134 | 253 | 232 | 190 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 67.1 | 47.8 | 41.2 | 38 | 40.1 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 80.2 | 83.6 | 75.3 | 67.2 | 70.8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 18.2 | 50.3 | 177 | 165 | 119 |
| Total Liabilities & Shareholders' Equity | 98.4 | 134 | 253 | 232 | 190 |
| Total Common Shares Outstanding |